248 related articles for article (PubMed ID: 23834763)
21. Matrix metalloproteinase 7 expression in ampullary carcinoma.
Kumari N; Singh RK; Krishnani N; Shukla P
Indian J Pathol Microbiol; 2015; 58(3):274-8. PubMed ID: 26275245
[TBL] [Abstract][Full Text] [Related]
22. Ampullary cancer.
Heinrich S; Clavien PA
Curr Opin Gastroenterol; 2010 May; 26(3):280-5. PubMed ID: 20168227
[TBL] [Abstract][Full Text] [Related]
23. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
24. Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
Xue Y; Vanoli A; Balci S; Reid MM; Saka B; Bagci P; Memis B; Choi H; Ohike N; Tajiri T; Muraki T; Quigley B; El-Rayes BF; Shaib W; Kooby D; Sarmiento J; Maithel SK; Knight JH; Goodman M; Krasinskas AM; Adsay V
Mod Pathol; 2017 Feb; 30(2):255-266. PubMed ID: 27739441
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.
Zhao XQ; Dong JH; Zhang WZ; Liu Z
Diagn Pathol; 2011 Oct; 6():98. PubMed ID: 21992455
[TBL] [Abstract][Full Text] [Related]
26. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
[TBL] [Abstract][Full Text] [Related]
27. Signet ring cell carcinoma of the ampulla of Vater: demonstration of a pancreatobiliary origin.
Gheza F; Cervi E; Pulcini G; Villanacci V; Giulini SM; Schiavo-Lena M; Ferrari AB; Bassotti G
Pancreas; 2011 Jul; 40(5):791-3. PubMed ID: 21673543
[No Abstract] [Full Text] [Related]
28. Expression of MUC1 and MUC2 in ampullary cancer.
Moriya T; Kimura W; Hirai I; Takasu N; Mizutani M
Int J Surg Pathol; 2011 Aug; 19(4):441-7. PubMed ID: 21700631
[TBL] [Abstract][Full Text] [Related]
29. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications.
Kohler I; Jacob D; Budzies J; Lehmann A; Weichert W; Schulz S; Neuhaus P; Röcken C
Am J Clin Pathol; 2011 Feb; 135(2):202-11. PubMed ID: 21228360
[TBL] [Abstract][Full Text] [Related]
31. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
32. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
[TBL] [Abstract][Full Text] [Related]
33. [Cytokeratins 7 and 20 immunohistochemistry in ampullary carcinomas].
Le Pessot F; Ranty ML; Hellot MF; Lemoine F; Ténière P; Testart J; Métayer J
Ann Pathol; 2004 Sep; 24(4):312-8. PubMed ID: 15567946
[TBL] [Abstract][Full Text] [Related]
34. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
36. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
Zhou H; Schaefer N; Wolff M; Fischer HP
Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
[TBL] [Abstract][Full Text] [Related]
37. The use of histopathological subtyping in patients with ampullary cancer: a nationwide analysis.
de Bakker J; Sommeijer D; Besselink M; Kazemier G; van Grieken N
World J Surg Oncol; 2022 Dec; 20(1):406. PubMed ID: 36566267
[TBL] [Abstract][Full Text] [Related]
38. Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.
Reid MD; Balci S; Ohike N; Xue Y; Kim GE; Tajiri T; Memis B; Coban I; Dolgun A; Krasinskas AM; Basturk O; Kooby DA; Sarmiento JM; Maithel SK; El-Rayes BF; Adsay V
Mod Pathol; 2016 Dec; 29(12):1575-1585. PubMed ID: 27586202
[TBL] [Abstract][Full Text] [Related]
39. Pathologic Subtypes of Ampullary Adenocarcinoma: Value of Ampullary MDCT for Noninvasive Preoperative Differentiation.
Ivanovic AM; Alessandrino F; Maksimovic R; Micev M; Ostojic S; Gore RM; Mortele KJ
AJR Am J Roentgenol; 2017 Mar; 208(3):W71-W78. PubMed ID: 28095024
[TBL] [Abstract][Full Text] [Related]
40. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
